AGIO
Agios Pharmaceuticals, Inc.
$55.54
Earnings Summary
Revenue | $8.96Mn |
Net Profits | $947.92Mn |
Net Profit Margins | 10574.69% |
Highlights
Agios Pharmaceuticals, Inc.’s revenue jumped 21.15% since last year same period to $8.96Mn in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 4.05% jump in its revenue since last 3-months.
Agios Pharmaceuticals, Inc.’s net profit jumped 1137.97% since last year same period to $947.92Mn in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 1086.2% jump in its net profits since last 3-months.
Agios Pharmaceuticals, Inc.’s net profit margin jumped 956.75% since last year same period to 10574.69% in the Q3 2024. On a quarterly growth basis, Agios Pharmaceuticals, Inc. has generated 1047.8% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Agios Pharmaceuticals, Inc. post its latest quarter earnings
EPS Estimate Current Quarter | 1.11 |
EPS Estimate Current Year | 1.11 |
Highlights
Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at 1.11 - a 169.38% jump from last quarter’s estimates.
Agios Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at 1.11.
Key Ratios
Key ratios of the Agios Pharmaceuticals, Inc. post its Q3 2024 earnings
Earning Per Share (EPS) | -2.42 |
Highlights
Agios Pharmaceuticals, Inc.’s earning per share (EPS) fell -47.56% since last year same period to -2.42 in the Q3 2024. This indicates that the Agios Pharmaceuticals, Inc. has generated -47.56% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-08-01 | -1.6 | -1.69 | -5.62% |
2024-05-02 | -1.65 | -1.45 | 12.12% |
2024-10-31 | 1.11 | -2.42 | -318.02% |
₹0 US Stocks a/c Opening Fee